Target intelligence / Profile preview

Microfold cell (M cell)

Target
M cell
Molecular classification
Other
01

Overview

Microfold cells, commonly known as M cells, are specialized epithelial cells located within the follicle-associated epithelium (FAE) of Peyer's patches and other mucosa-associated lymphoid tissues (MALT) (Mabbott et al., 2013, Nature Reviews Microbiology). Unlike typical enterocytes, M cells possess a unique morphology characterized by a lack of traditional microvilli and a specialized basal pocket that houses immune cells such as dendritic cells and B cells (Neutra et al., 1996, Annual Review of Immunology). Their central biological role is the sampling of lumenal antigens and pathogens, which they transport via transcytosis from the apical surface to the underlying lymphoid tissue to initiate a targeted mucosal immune response (Hase et al., 2009, Nature). While critical for immune surveillance, M cells are frequently exploited as entry portals by various pathogens, including Salmonella typhimurium, Shigella, and Prions, which can lead to systemic infection (Ohno et al., 2009, Nature). In the context of drug development, M cells represent a significant target for the oral delivery of vaccines and macromolecular therapeutics, as they provide a unique pathway to bypass the degradative environment of the intestinal lumen (Azizi et al., 2010, Journal of Controlled Release). Current research focuses on utilizing M-cell-specific surface markers, such as Glycoprotein 2 (GP2), to direct vaccine-loaded nanoparticles or ligand-conjugated antigens for efficient mucosal immunization (Kanaya et al., 2012, Polymer Journal).

Other names
Microfold cellMembranous cellM-cellFollicle-associated epithelial cell
02

Mechanism of action

M cells facilitate the transport of lumenal antigens, particulate matter, and pathogens across the epithelial barrier via apical-to-basal transcytosis for presentation to underlying dendritic cells and lymphocytes.

03

Biological functions

Antigen samplingImmune responseTranscytosisImmune surveillanceMucosal immunity
04

Disease associations

InfectionInflammationInflammatory bowel diseasePrion disease
05

Safety considerations

Pathogen exploitation of M cell transcytosis for systemic entryLow density of M cells in the intestinal tract complicating targeting efficiencyInterspecies variability in M cell markers and frequencyPotential for unintended systemic inflammatory responses to delivered cargo
06

Interacting drugs

Oral vaccines (e.g., Vaxchora, non-specific)

3 more in the full profile.

07

Biomarkers

Glycoprotein 2 (GP2)Tumor necrosis factor alpha-induced protein 2 (TNFAIP2)Spi-B transcription factor (SPIB)C-C motif chemokine ligand 20 (CCL20)MARCKS-like protein 1 (MARCKSL1)

Beyond the preview

Go deeper on Microfold cell (M cell).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Microfold cell (M cell).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call